Results
|
|
21061.
|
|
|
|
21062.
|
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. [electronic resource] by
- Candelaria, M
- Gallardo-Rincón, D
- Arce, C
- Cetina, L
- Aguilar-Ponce, J L
- Arrieta, O
- González-Fierro, A
- Chávez-Blanco, A
- de la Cruz-Hernández, E
- Camargo, M F
- Trejo-Becerril, C
- Pérez-Cárdenas, E
- Pérez-Plasencia, C
- Taja-Chayeb, L
- Wegman-Ostrosky, T
- Revilla-Vazquez, A
- Dueñas-González, A
Producer: 20071212
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 18
Availability: No items available.
|
|
|
21063.
|
|
|
|
21064.
|
|
|
|
21065.
|
|
|
|
21066.
|
|
|
|
21067.
|
|
|
|
21068.
|
|
|
|
21069.
|
|
|
|
21070.
|
|
|
|
21071.
|
|
|
|
21072.
|
|
|
|
21073.
|
|
|
|
21074.
|
|
|
|
21075.
|
|
|
|
21076.
|
Disruption of an M. tuberculosis membrane protein causes a magnesium-dependent cell division defect and failure to persist in mice. [electronic resource] by
- Goodsmith, Nichole
- Guo, Xinzheng V
- Vandal, Omar H
- Vaubourgeix, Julien
- Wang, Ruojun
- Botella, Hélène
- Song, Shuang
- Bhatt, Kamlesh
- Liba, Amir
- Salgame, Padmini
- Schnappinger, Dirk
- Ehrt, Sabine
Producer: 20160119
In:
PLoS pathogens vol. 11
Availability: No items available.
|
|
|
21077.
|
|
|
|
21078.
|
|
|
|
21079.
|
|
|
|
21080.
|
|